H型高血压诊断与治疗专家共识

被引:118
作者
李建平 [1 ]
卢新政 [2 ]
霍勇 [1 ]
李南方 [3 ]
宋雷 [4 ]
孙英贤 [5 ]
施仲伟 [6 ]
王滨燕 [7 ]
杨新春 [8 ]
谢良地 [9 ]
赵连友 [10 ]
雷寒 [11 ]
孙宁玲 [12 ]
机构
[1] 北京大学第一医院
[2] 江苏省人民医院
[3] 新疆维吾尔自治区人民医院
[4] 中国医学科学院阜外医院
[5] 中国医科大学附属第一医院
[6] 上海交通大学医学院附属瑞金医院
[7] 南方医科大学南方医院
[8] 北京朝阳医院
[9] 福建医科大学附属第一医院
[10] 第四军医大学唐都医院
[11] 重庆医科大学附属第一医院
[12] 北京大学人民医院
关键词
D O I
暂无
中图分类号
R544.1 [高血压];
学科分类号
100201 [内科学];
摘要
<正>中国第三次全国死因调查报告表明,脑血管病已成为我国首位死亡原因。同时,我国缺血性脑卒中仍以每年8.7%的速率增长[1]。因此,我国心脑血管病防治的重点是预防脑卒中。高血压是脑卒中发病最主要的危险因素,在中国高血压人群中开展的上海老龄人群硝苯地平研究
引用
收藏
页码:23 / 28+6 +6
页数:7
相关论文
共 16 条
[1]
Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis [J].
Huo, Y. ;
Qin, X. ;
Wang, J. ;
Sun, N. ;
Zeng, Q. ;
Xu, X. ;
Liu, L. ;
Xu, X. ;
Wang, X. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (06) :544-551
[2]
Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study.[J].Amytis Towfighi;Daniela Markovic;Bruce Ovbiagele.Journal of the Neurological Sciences.2010, 1
[3]
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial [J].
Hankey, G. J. ;
Eikelboom, J. W. ;
Baker, R. I. ;
Gelavis, A. ;
Hickling, S. C. ;
Jamrozik, K. ;
van Bockxmeer, F. M. ;
Vasikaran, S. ;
Hankey, G. J. ;
Chen, C. ;
Eikelboom, J. W. ;
Lees, K. R. ;
Yi, Q. ;
Hankey, G. J. ;
Algra, A. ;
Chen, C. ;
Wong, M. C. ;
Cheung, R. ;
Wong, L. ;
Divjak, I. ;
Ferro, J. ;
de Freitas, G. ;
Gommans, J. ;
Groppa, S. ;
Hill, M. ;
Spence, J. D. ;
Lees, K. R. ;
Lisheng, L. ;
Navarro, J. ;
Ranawaka, U. ;
Ricci, S. ;
Schmidt, R. ;
Slivka, A. ;
Tan, K. ;
Tsiskaridze, A. ;
Uddin, W. ;
Vanhooren, G. ;
Xavier, D. ;
Armitage, J. ;
Hobbs, M. ;
Le, M. ;
Sudlow, C. ;
Wheatley, K. ;
Yi, Q. ;
Brown, W. ;
Bulder, M. ;
Eikelboom, J. W. ;
Hankey, G. J. ;
Ho, W. K. ;
Jamrozik, K. .
LANCET NEUROLOGY, 2010, 9 (09) :855-865
[4]
Epidemiological Transition of Stroke in China: Twenty-One–Year Observational Study From the Sino-MONICA-Beijing Project.[J].Dong Zhao;Jing Liu;Wei Wang;Zhechun Zeng;Jun Cheng;Jun Liu;Jiayi Sun;Zhaosu Wu.Stroke.2008, 6
[5]
Homocysteine-lowering therapy: a role in stroke prevention?.[J].J David Spence.Lancet Neurology.2007, 9
[6]
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis [J].
Wang, Xiaobin ;
Qin, Xianhui ;
Demirtas, Hakan ;
Li, Jianping ;
Mao, Guangyun ;
Huo, Yong ;
Sun, Ningling ;
Liu, Lisheng ;
Xu, Xiping .
LANCET, 2007, 369 (9576) :1876-1882
[7]
Homocysteine and stroke: evidence on a causal link from mendelian randomisation [J].
Casas, JP ;
Bautista, LE ;
Smeeth, L ;
Sharma, P ;
Hingorani, AD .
LANCET, 2005, 365 (9455) :224-232
[8]
Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke - A multicenter case-control study in China [J].
Li, ZH ;
Sun, L ;
Zhang, HY ;
Liao, YH ;
Wang, DW ;
Zhao, BR ;
Zhu, ZM ;
Zhao, JZ ;
Ma, AQ ;
Han, Y ;
Wang, YB ;
Shi, Y ;
Ye, J ;
Hui, RT .
STROKE, 2003, 34 (09) :2085-2090
[9]
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [J].
Lewington, S ;
Clarke, R ;
Qizilbash, N ;
Peto, R ;
Collins, R .
LANCET, 2002, 360 (9349) :1903-1913
[10]
Stroke is more common than myocardial infarction in hypertension: Analysis based on 11 major randomized intervention trials [J].
Kjeldsen, SE ;
Julius, S ;
Hedner, T ;
Hansson, L .
BLOOD PRESSURE, 2001, 10 (04) :190-192